Performance analysis of Minerva Neurosciences (NERV)
Annual Return
Over the past 3 years, NERV has had an average annual return of -10.97%, underperforming the benchmark SPY, which returned +22.45% annual.
Over the past 5 years, NERV has had an average annual return of -27.43%, underperforming the benchmark SPY, which returned +13.88% annual.
Over the past 10 years, NERV has had an average annual return of -26.47%, underperforming the benchmark SPY, which returned +15.44% annual.
Since Jul 1, 2014, NERV has had an average annual return of -17.78%, underperforming the benchmark SPY, which returned +13.79% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +16.37% | +81.05% | -63.89% | +286.32% | -75.15% | -65.77% | -67.09% | +5.49% | +11.40% | -48.51% | +93.57% | +0.83% |
| 2014 | |||||||||||
| -0.50% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.96% | +62.57% | -8.72% | +7.39% | -24.16% | -4.64% | +16.37% | ||||||
| 2025 | +3.92% | -27.67% | +1.74% | -1.71% | -7.83% | +11.64% | +8.73% | +26.42% | -10.86% | +99.54% | -0.46% | -3.82% | +81.05% |
| 2024 | +37.37% | -68.38% | -3.44% | -8.44% | +7.99% | +25.05% | -6.83% | -7.82% | -2.47% | -10.33% | -5.86% | -1.50% | -63.89% |
| 2023 | +50.15% | -9.72% | -25.78% | +74.92% | +112.95% | +53.12% | +4.08% | -12.01% | -17.52% | -30.15% | +62.85% | -21.64% | +286.32% |
| 2022 | +3.02% | -14.44% | +17.57% | -38.63% | -21.50% | +3.48% | -19.01% | +320.76% | -18.19% | -71.26% | +33.39% | -54.99% | -75.15% |
| 2021 | +36.32% | -2.83% | -5.82% | -18.48% | +23.95% | -21.35% | -20.70% | +0% | -5.43% | -19.54% | -30.64% | -17.51% | -65.77% |
| 2020 | +14.35% | -10.46% | -17.31% | +49.01% | -58.64% | -2.69% | -3.47% | -8.75% | -0% | +0.95% | +21.18% | -39.84% | -67.09% |
| 2019 | -2.37% | +20.51% | -0.88% | -6.23% | -29.31% | +8.06% | +17.93% | +7.54% | +8.54% | -38.84% | +31.86% | +13.75% | +5.49% |
| 2018 | +5.79% | -17.97% | +19.05% | +4.79% | +34.35% | -6.25% | -2.42% | +29.19% | +20.67% | -12.59% | -27.90% | -14.79% | +11.40% |
| 2017 | -9.78% | -17.45% | -7.43% | -6.17% | +8.55% | +7.27% | -24.86% | -9.02% | +25.62% | -17.11% | -8.73% | +5.22% | -48.51% |
Drawdown analysis of Minerva Neurosciences (NERV)
The maximum drawdown for the NERV was -98.86%, occurring on Apr 9, 2025. This drawdown has not yet recovered.
The current NERV drawdown is -96.02%.
Since Jul 1, 2014 NERV has experienced the following drawdowns:
- 50% or more: 3 times
- 40% or more: 3 times
- 30% or more: 4 times
- 20% or more: 4 times
- 10% or more: 6 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -98.86% | May 26, 2020 | 1225 | Apr 9, 2025 | Ongoing | Ongoing | Ongoing |
| -71.63% | Sep 20, 2016 | 777 | Oct 22, 2019 | 146 | May 21, 2020 | 923 |
| -53.73% | Sep 10, 2014 | 430 | May 25, 2016 | 1 | May 26, 2016 | 431 |
| -33.29% | Jun 2, 2016 | 17 | Jun 27, 2016 | 59 | Sep 20, 2016 | 76 |
| -17.13% | Jul 28, 2014 | 6 | Aug 5, 2014 | 24 | Sep 9, 2014 | 30 |
| -13.98% | Jul 14, 2014 | 1 | Jul 15, 2014 | 9 | Jul 28, 2014 | 10 |
| -4.07% | May 26, 2016 | 1 | May 27, 2016 | 1 | May 31, 2016 | 2 |
| -3.75% | Jul 3, 2014 | 1 | Jul 7, 2014 | 3 | Jul 10, 2014 | 4 |
| -1.99% | May 21, 2020 | 1 | May 22, 2020 | 1 | May 26, 2020 | 2 |
| -1.04% | Jul 10, 2014 | 1 | Jul 11, 2014 | 1 | Jul 14, 2014 | 2 |
| -0.83% | Jul 1, 2014 | 1 | Jul 2, 2014 | 1 | Jul 3, 2014 | 2 |